BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12536358)

  • 1. GnRH agonists, antagonists, and assisted conception.
    van Loenen AC; Huirne JA; Schats R; Hompes PG; Lambalk CB
    Semin Reprod Med; 2002 Nov; 20(4):349-64. PubMed ID: 12536358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonists vs antagonists.
    Tarlatzis BC; Kolibianakis EM
    Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH antagonists.
    Coccia ME; Comparetto C; Bracco GL; Scarselli G
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S44-56. PubMed ID: 15196716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone analogs: Understanding advantages and limitations.
    Kumar P; Sharma A
    J Hum Reprod Sci; 2014 Jul; 7(3):170-4. PubMed ID: 25395741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-stimulating hormone secretion from monkey pituitary cultures by activating the GnRH I receptor.
    Okada Y; Murota-Kawano A; Kakar SS; Winters SJ
    Biol Reprod; 2003 Oct; 69(4):1356-61. PubMed ID: 12801988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological assessment criteria during antagonist protocols].
    Plachot M
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S32-5. PubMed ID: 15643685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH-antagonists in reproductive medicine.
    Griesinger G; Felberbaum R; Diedrich K
    Arch Gynecol Obstet; 2005 Dec; 273(2):71-8. PubMed ID: 15991015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are GnRH antagonists comparable to agonists for use in IVF?
    Huirne JA; Homburg R; Lambalk CB
    Hum Reprod; 2007 Nov; 22(11):2805-13. PubMed ID: 17872909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New GnRH analogs in canine reproduction.
    Gobello C
    Anim Reprod Sci; 2007 Jul; 100(1-2):1-13. PubMed ID: 16979859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels.
    Huirne JA; van Loenen AC; Schats R; McDonnell J; Hompes PG; Schoemaker J; Homburg R; Lambalk CB
    Hum Reprod; 2004 Oct; 19(10):2206-15. PubMed ID: 15333605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
    De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
    Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone and reproductive medicine.
    Shalev E; Leung PC
    J Obstet Gynaecol Can; 2003 Feb; 25(2):98-113. PubMed ID: 12577127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH antagonist in in vitro fertilization: where we are now.
    Shapiro DB; Mitchell-Leef D
    Minerva Ginecol; 2003 Oct; 55(5):373-88. PubMed ID: 14581880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GnRH agonists versus antagonists in fertilization in vitro].
    Frydman R
    Rev Prat; 2005; Spec. No():30-4. PubMed ID: 15822869
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.
    Moghissi KS
    Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.